FDA Approved: LANOXIN — Supplemental Application (Covis Pharma US, Inc)

View source ↗

Summary

The FDA approved a supplemental application for LANOXIN (digoxin) submitted by Covis Pharma US, Inc. The action updates the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Heart Failure

Drugs mentioned

• LANOXIN (Digoxin)

Snippet

SUPPL AP for LANOXIN (DIGOXIN)